Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues surrounding MDI formulation development with non-CFC propellants.

M J Kontny1, G Destefano, P D Jager

  • 1Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.

Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|March 4, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interactions of water with cellulose- and starch-derived pharmaceutical excipients.

Pharmaceutical research·2013
Same author

Model for moisture transport into inhalation aerosols.

Pharmaceutical research·1996
Same author

The role of 5-lipoxygenase products in preclinical models of asthma.

The Journal of allergy and clinical immunology·1993
Same author

Value and limitations of exercise stress testing to predict the functional results of coronary artery bypass grafting.

International journal of cardiac imaging·1993
Same author

Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children.

Annals of allergy·1990
Same author

Reaction plane approach for estimating the effects of buffers on the dissolution rate of acidic drugs.

Journal of pharmaceutical sciences·1988
Same journal

ASTRA Satellite Symposium -"The Importance of Size".

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Aerosols for Medical Applications (GAeF Satellite Meeting).

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Mucus and cilia symposium.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Aerosol delivery systems.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Standardization.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Modeling.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
See all related articles

Reformulating metered-dose inhalers (MDIs) without chlorofluorocarbons (CFCs) requires new propellants like HFA-134a and HFA-227. Challenges include finding compatible valves, suspending agents, and manufacturing processes for safe and effective inhalers.

Area of Science:

  • Pharmaceutical Sciences
  • Chemical Engineering
  • Environmental Science

Background:

  • Metered-dose inhalers (MDIs) traditionally use chlorofluorocarbon (CFC) propellants.
  • CFCs are being phased out due to environmental concerns, necessitating the development of alternative propellants.
  • No single alternative propellant perfectly replicates the physical-chemical properties of CFCs for pharmaceutical applications.

Purpose of the Study:

  • To identify and evaluate potential alternative propellants for MDIs.
  • To outline the challenges and requirements for reformulating MDIs with new propellants.
  • To assess the suitability of hydrofluoroalkanes (HFAs) as CFC replacements.

Main Methods:

  • Review of alternative propellant options including hydrofluorocarbons (HFCs), hydrochlorofluorocarbons (HCFCs), and hydrocarbons (HCs).

Related Experiment Videos

  • Evaluation of HFA-134a and HFA-227 based on environmental impact (ozone depletion, global warming potential) and physical-chemical properties (flammability, density, vapor pressure).
  • Identification of technical requirements for MDI reformulation, including valve compatibility, suspending agents, and manufacturing processes.

    • Main Results:

    • HFA-134a and HFA-227 are identified as the most promising CFC replacement propellants due to favorable environmental profiles and suitable properties.
    • Significant technical hurdles remain, including the need for propellant-compatible metering valves and gaskets.
    • Optimization or identification of new suspending agents and adaptation of manufacturing technologies are crucial for successful reformulation.

    Conclusions:

    • The transition to non-CFC MDIs is feasible with propellants like HFA-134a and HFA-227, but requires significant technical development.
    • Addressing challenges in formulation, device components, and manufacturing is essential for ensuring product stability, safety, and efficacy.
    • Successful reformulation will necessitate rigorous testing and regulatory approval from global authorities.